Search scope:
排序: Display mode:
MicroRNAs and lung cancers: from pathogenesis to clinical implications
Ji Qi, David Mu
Frontiers of Medicine 2012, Volume 6, Issue 2, Pages 134-155 doi: 10.1007/s11684-012-0188-4
Lung cancer is the leading cause of cancer-related deaths in the US and worldwide.functions of small-RNA-based, posttranscriptional gene regulators, i.e. microRNAs, in the pathogenesis of lungmicroRNAs as markers for diagnosis, prognosis and the promising field of microRNA-based novel therapies for lung
Keywords: lung biology lung cancer microRNA
Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine
Hongmei Xu, Xuetao Cao
Frontiers of Medicine 2011, Volume 5, Issue 4, Pages 323-332 doi: 10.1007/s11684-011-0172-4
Curbing the burden of lung cancer
Alexandra Urman,H. Dean Hosgood
Frontiers of Medicine 2016, Volume 10, Issue 2, Pages 228-232 doi: 10.1007/s11684-016-0447-x
Lung cancer contributes substantially to the global burden of disease and healthcare costs.Focusing on prevention is an important factor to reduce the burden of screening, treatment, and lungThe International Agency for Research on Cancer has identified several lung carcinogens, which we believeTo curb the societal burden of lung cancer, healthcare resources need to be focused on early detectionlung cancer.
Keywords: lung cancer screening risk factors environmental
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 714-728 doi: 10.1007/s11684-022-0959-5
Keywords: FRMD6 lung cancer mTOR pathway
Pathogenesis sequences in Gejiu miners with lung cancer: an introduction
Li Bian,Yonghua Ruan,Liju Ma,Hairong Hua,Li Zhou,Xiaoyu Tuo,Zheyan Zhou,Ting Li,Shiyue Liu,Kewei Jin
Frontiers of Medicine 2015, Volume 9, Issue 3, Pages 344-349 doi: 10.1007/s11684-015-0399-6
Tin miners in Gejiu, Yunnan Province, China are at high risk of developing lung cancer with significantpresented pathological characteristics, such as fibroplasia in carcinomas, peri-cancerous tissue in lungOur findings suggested that pulmonary fibrosis may increase the risk and promote the occurrence of lungcancer, which can lead to lung fiber hyperplasia.
Keywords: Yunnan tin mine miners lung cancer
The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, China
Yize Xiao, Ying Shao, Xianjun Yu, Guangbiao Zhou
Frontiers of Medicine 2012, Volume 6, Issue 4, Pages 388-394 doi: 10.1007/s11684-012-0233-3
Keywords: lung cancer Xuanwei smoky coal combustion polycyclic aromatic hydrocarbons epidemiology
Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
Bo PENG BA , Jinnong ZHANG MD , Jamile S. WOODS MD , Wei PENG MD, PhD
Frontiers of Medicine 2009, Volume 3, Issue 3, Pages 245-255 doi: 10.1007/s11684-009-0044-3
Keywords: lung cancer carcinoma non-small cell lung cancer molecular markers targeted therapy
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 760-765 doi: 10.1007/s11684-021-0899-5
Keywords: lung transplantation donation after brain death waitlist
Jay H. Ryu, Xinlun Tian, Misbah Baqir, Kaifeng Xu
Frontiers of Medicine 2013, Volume 7, Issue 3, Pages 316-327 doi: 10.1007/s11684-013-0269-z
Diffuse cystic lung diseases are uncommon but can present a diagnostic challenge because increasingCyst in the lung is defined as a round parenchymal lucency with a well-defined thin wall (<2 mm thickness“Diffuse” distribution in the lung implies involvement of all lobes.Diffuse lung involvement with cystic lesions can be seen in pulmonary lymphangioleiomyomatosis, pulmonaryHigh-resolution computed tomography of the chest helps define morphologic features of the lung lesions
Keywords: cyst lung disease interstitial lung disease lymphangioleiomyomatosis Langerhans’ cell histiocytosis Birt-Hogg-Dubé
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 389-402 doi: 10.1007/s11684-021-0856-3
Keywords: severe community-acquired pneumonia lung microbiota clinical improvements 7-category ordinal scale
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 18-42 doi: 10.1007/s11684-022-0976-4
Keywords: non-small cell lung cancer driver mutations treatment strategy resistant mechanism immune-checkpoint
Min ZHU, Xiang-Ning FU, Xiao-Ping CHEN
Frontiers of Medicine 2011, Volume 5, Issue 1, Pages 53-60 doi: 10.1007/s11684-011-0121-2
Video-assisted thoracoscopic surgery (VATS) provides a new approach for treating early-stage lungHowever, there is still much debate on the role of VATS in lobectomy for the treatment of lung cancerlymph node dissection, and long-term survival have made some surgeons apprehensive of its validity for lungreview the development of thoracoscopy, the present status of VATS for early stage of non-small cell lung
Keywords: non-small cell lung cancer video-assisted thoracoscopic surgery lobectomy
Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 766-772 doi: 10.1007/s11684-021-0916-8
Keywords: anlotinib chemotherapy short-term relapsed small-cell lung cancer
Orlistat induces ferroptosis-like cell death of lung cancer cells
Frontiers of Medicine 2021, Volume 15, Issue 6, Pages 922-932 doi: 10.1007/s11684-020-0804-7
Keywords: orlistat ferroptosis FAF2 lung cancer
Four-protein model for predicting prognostic risk of lung cancer
Frontiers of Medicine 2022, Volume 16, Issue 4, Pages 618-626 doi: 10.1007/s11684-021-0867-0
Keywords: lung cancer HSP90β decision tree model prognosis
Title Author Date Type Operation
MicroRNAs and lung cancers: from pathogenesis to clinical implications
Ji Qi, David Mu
Journal Article
Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine
Hongmei Xu, Xuetao Cao
Journal Article
FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progression
Journal Article
Pathogenesis sequences in Gejiu miners with lung cancer: an introduction
Li Bian,Yonghua Ruan,Liju Ma,Hairong Hua,Li Zhou,Xiaoyu Tuo,Zheyan Zhou,Ting Li,Shiyue Liu,Kewei Jin
Journal Article
The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, China
Yize Xiao, Ying Shao, Xianjun Yu, Guangbiao Zhou
Journal Article
Molecular markers and pathogenically targeted therapy in non-small cell lung cancer
Bo PENG BA , Jinnong ZHANG MD , Jamile S. WOODS MD , Wei PENG MD, PhD
Journal Article
Outcomes of patients awaiting lung transplantation after the implementation of donation after brain death
Journal Article
Clinical factors associated with composition of lung microbiota and important taxa predicting clinical
Journal Article
Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future
Journal Article
Lobectomy by video-assisted thoracoscopic surgery (VATS) for early stage of non-small cell lung cancer
Min ZHU, Xiang-Ning FU, Xiao-Ping CHEN
Journal Article
Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup
Journal Article